Urenco Isotopes provides the world with stable and medical isotopes for medical, research and industry uses.
Visit our Isotopes websiteSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur increased order book and solid financial and operational performance provide basis for future growth.
Read our latest report01 April 2021
Urenco’s programme to enable the production of LEU+, enriched uranium up to 10% U235, at its US and UK sites (Urenco UK and UUSA) is progressing quickly with the completion of detailed technical feasibility and plant optimisation plans.
As a leader in the nuclear industry, Urenco is well positioned to provide the enrichment services needed to support the nuclear industry’s efficiencies, advancements, and innovations in fuel production.
This new product can be used in existing light water reactors seeking to achieve higher levels of safety and improved economics. Urenco’s existing advanced gas centrifuge technology is capable of producing it and few modifications will be needed to the current facilities at Urenco UK and UUSA.
LEU+ is a positive initial step towards the subsequent potential production of other next generation fuels, as announced previously.
Harro Blokhuis, Urenco Group Business Development Director, said: “Urenco is advancing the next generation of fuels as an important part of achieving greater efficiencies within the industry and making a valuable contribution to decarbonisation goals.
“We have the knowledge and experience to play a leading role in this area, which will provide an enhanced service for our customers and wider benefits for society.”
About Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries